128 related articles for article (PubMed ID: 34571355)
1. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis.
Shi S; Ma HY; Zhang ZG
Pathol Res Pract; 2021 Nov; 227():153624. PubMed ID: 34571355
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and Prognostic Role of STAT3/p-STAT3 in Breast Cancer Patients in China: A Meta-Analysis.
Li Y; Wang Y; Shi Z; Liu J; Zheng S; Yang J; Liu Y; Yang Y; Chang F; Yu W
Sci Rep; 2019 Aug; 9(1):11243. PubMed ID: 31375715
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis Reveals
Ma H; Liu Z; Li H; Guo X; Guo S; Qu P; Wang Y
Comput Math Methods Med; 2021; 2021():8494260. PubMed ID: 34671420
[TBL] [Abstract][Full Text] [Related]
5. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
6. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
Zhang Y; Li X; Zhang J; Liang H
Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
[TBL] [Abstract][Full Text] [Related]
7. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.
Takemoto S; Ushijima K; Kawano K; Yamaguchi T; Terada A; Fujiyoshi N; Nishio S; Tsuda N; Ijichi M; Kakuma T; Kage M; Hori D; Kamura T
Br J Cancer; 2009 Sep; 101(6):967-72. PubMed ID: 19638983
[TBL] [Abstract][Full Text] [Related]
8. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
10. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
11. LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.
Lin J; Nong LL; Li MQ; Yang FC; Wang SH; Liu MJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4673-4679. PubMed ID: 31210293
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
14. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.
Sonnenblick A; Shriki A; Galun E; Axelrod JH; Daum H; Rottenberg Y; Hamburger T; Mali B; Peretz T
Clin Transl Oncol; 2012 Mar; 14(3):232-6. PubMed ID: 22374428
[TBL] [Abstract][Full Text] [Related]
16. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
17. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
Shan D; Shang Y; Hu T
Oncol Res; 2019 Feb; 27(3):349-358. PubMed ID: 29716674
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC
Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777
[TBL] [Abstract][Full Text] [Related]
20. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]